404 related articles for article (PubMed ID: 28326487)
21. Impaired Store-Operated Calcium Entry and STIM1 Loss Lead to Reduced Insulin Secretion and Increased Endoplasmic Reticulum Stress in the Diabetic β-Cell.
Kono T; Tong X; Taleb S; Bone RN; Iida H; Lee CC; Sohn P; Gilon P; Roe MW; Evans-Molina C
Diabetes; 2018 Nov; 67(11):2293-2304. PubMed ID: 30131394
[TBL] [Abstract][Full Text] [Related]
22. Identification of drug-regulated genes in osteosarcoma cells.
Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
Zhou X; Natino D; Zhai X; Gao Z; He X
Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
[TBL] [Abstract][Full Text] [Related]
24. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma.
Chen R; Li X; He B; Hu W
Mol Med Rep; 2017 Mar; 15(3):1326-1334. PubMed ID: 28138700
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.
Vanas V; Haigl B; Stockhammer V; Sutterlüty-Fall H
PLoS One; 2016; 11(8):e0161023. PubMed ID: 27513462
[TBL] [Abstract][Full Text] [Related]
27. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells.
Zhu W; Mao X; Wang W; Chen Y; Li D; Li H; Dou P
Pharmazie; 2018 Feb; 73(2):80-86. PubMed ID: 29442009
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.
Zhang Z; Zhou Q; Luo F; Zhou R; Xu J; Xiao J; Dai F; Song L
Hum Cell; 2021 Sep; 34(5):1558-1568. PubMed ID: 34164774
[TBL] [Abstract][Full Text] [Related]
29. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line.
Ziyan W; Yang L
Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586
[TBL] [Abstract][Full Text] [Related]
31. Id3-mediated enhancement of cisplatin-induced apoptosis in a sarcoma cell line MG-63.
Koyama T; Suzuki H; Imakiire A; Yanase N; Hata K; Mizuguchi J
Anticancer Res; 2004; 24(3a):1519-24. PubMed ID: 15274318
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of STIM1 inhibits 6-hydroxydopamine-induced oxidative stress through attenuating calcium-dependent ER stress and mitochondrial dysfunction in undifferentiated PC12 cells.
Li B; Xiao L; Wang ZY; Zheng PS
Free Radic Res; 2014 Jul; 48(7):758-68. PubMed ID: 24720513
[TBL] [Abstract][Full Text] [Related]
33. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
[TBL] [Abstract][Full Text] [Related]
34. miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis.
Song YD; Li DD; Guan Y; Wang YL; Zheng J
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):75-79. PubMed ID: 28980925
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
[TBL] [Abstract][Full Text] [Related]
36. STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer.
Kutschat AP; Hamdan FH; Wang X; Wixom AQ; Najafova Z; Gibhardt CS; Kopp W; Gaedcke J; Ströbel P; Ellenrieder V; Bogeski I; Hessmann E; Johnsen SA
Cancer Res; 2021 Jun; 81(11):2943-2955. PubMed ID: 33436389
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced resistance to cisplatin-mediated apoptosis in osteosarcoma cells is reversed by gambogic acid independently of HIF-1α.
Zhao W; Xia SQ; Zhuang JP; Zhang ZP; You CC; Yan JL; Xu GP
Mol Cell Biochem; 2016 Sep; 420(1-2):1-8. PubMed ID: 27473145
[TBL] [Abstract][Full Text] [Related]
38. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
[TBL] [Abstract][Full Text] [Related]
39. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
40. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
Zhou Q; Hu T; Xu Y
J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
